Private Equity Conversations with Fexingo · 2026-07-03 · 8 min
Key moments - from our scoring
Substance score
58 / 100
Five dimensions, 20 points each
The emergency room staffing roll-up represents a case study in how regulatory change can collapse a private equity thesis even at massive scale. Envision Healthcare, built through decades of acquisitions to employ 25,000 clinicians and dominate ER staffing nationwide, was taken private by KKR for nearly $10 billion in 2018. The economic logic was straightforward: consolidate fragmented physician groups, stay out-of-network, and leverage scale to bill insurers at premium rates - generating the infamous 'surprise bills' that caught patients and regulators' attention. Congress's No Surprises Act (effective 2022) shifted billing disputes to independent arbitration where insurers typically win by offering median in-network rates, gutting the revenue model. Envision filed for Chapter 11 in 2023 with KKR losing most of its equity; competitor TeamHealth, owned by Apollo Global Management, faced similar struggles and DOJ settlements over upcoding allegations. Beyond financial returns, the roll-up also pressured physicians to meet productivity targets and admission quotas, driving burnout in an already stressed profession. Transaction volume in physician staffing M&A has since dropped significantly. Hospitals like HCA Healthcare are now moving ER staffing in-house, further eroding the independent staffing model's viability and forcing PE capital toward less-regulated adjacencies like hospitalist management and telemedicine.
The 2022 No Surprises Act eliminated surprise billing and shifted payment disputes to arbitration where insurers win by offering median in-network rates instead of premium out-of-network rates that the roll-up model depended on. Envision filed for Chapter 11 bankruptcy in 2023 and equity was wiped out.
Under the law, when disputes arise between staffing firms and insurers over out-of-network physician billing, independent arbitrators typically award payment at the median in-network rate rather than the higher rates staffing firms previously charged, directly reducing their revenue models.
Upcoding is billing for more severe medical conditions than were actually treated; TeamHealth settled a major Department of Justice investigation in 2022 for over $300 million tied to upcoding allegations.
Yes - HCA Healthcare, the largest for-profit hospital chain, recently announced plans to move more ER staffing to directly employed physicians, directly threatening the independent staffing model's customer base.
PE-backed firms impose productivity targets requiring physicians to see more patients per shift and hit billing thresholds; some were pressured to increase admission rates even when medically unnecessary, leading to lawsuits and increased burnout.
Our reviewer’s read on each dimension, with quotes from the episode.
The episode delivers solid structural analysis of how PE's physician staffing roll-up model broke down - regulatory capture via the No Surprises Act, arbitration mechanics, revenue pressure, and shifts to hospital employment. However, it lacks granular operational detail: no specific physician compensation data, no concrete examples of productivity target abuse beyond one lawsuit mention, and limited numbers on arbitration outcomes ('early data shows insurers often win' is vague). The core insight about regulatory shifts destroying PE returns is strong but not paired with enough fresh empirical substance.
when a private equity firm buys a physician staffing group, it often imposes productivity targets. You need to see more patients per shift, you need to hit certain billing thresholds. That drives burnout in a profession already experiencing high rates of it.
That law basically took away the leverage that these staffing firms had. It says if you go to an in-network facility, you can't be balance-billed for the out-of-network physician.
The framing - PE roll-ups meeting regulatory headwinds - is solid but not novel; the surprise billing crisis and No Surprises Act were widely covered 2021 - 2023. The guest does offer one fresh structural insight: the tension between PE efficiency extraction and clinical judgment in human-capital-intensive regulated sectors, and the observation that hospital in-sourcing of staffing threatens the entire model. But most takes (KKR's loss, Envision bankruptcy, shift to employed physicians) were already public knowledge by mid-2024.
It's not just 'PE buys doctors, makes money.' It's 'PE buys doctors, law changes, returns evaporate, doctors are left in a worse position.'
you can't treat them like a hardware store employee
The guests (Lucas and Luna, hosts of a PE podcast) are knowledgeable synthesizers of PE history and macro-industry trends, but neither appears to be a working PE investor, physician staffing executive, or hospital operator with direct deal experience. They are informed commentators with platform credibility but lack hands-on practitioner caliber. The episode reads as thoughtful journalism rather than insider testimony.
By now, listeners of this show know the playbook.
That's what makes this show interesting - watching the cycle repeat with a new twist each time.
The episode names key players (Envision, TeamHealth, KKR, Apollo, NorthStar Anesthesia, HCA Healthcare) and cites concrete facts: 25,000 clinicians at Envision by 2018, KKR's ~$10B deal, No Surprises Act effective 2022, Envision Chapter 11 in 2023, TeamHealth's $300M+ DOJ settlement in 2022. However, it lacks depth: no physician salary ranges, no specifics on arbitration case outcomes, no numbers on transaction volume decline post-Act, and vague references ('another big lawsuit') without names or dates. Claims about hospital in-sourcing and future unionization are stated without supporting data.
By 2018 it employed something like 25,000 clinicians
KKR took it private in a deal valued at nearly ten billion dollars, including debt
The two hosts build a logical narrative arc with good layering (the roll-up playbook → surprise billing vulnerability → regulatory hit → labor cost/burnout tension → future substitution), and they do push back on oversimplification (e.g., noting the physician burnout angle isn't just financial efficiency). However, questions are mostly rhetorical scaffolding rather than challenging: no pushback on the claim that PE will simply 'adapt,' no exploration of whether physician unionization would actually happen, and no interrogation of hospital in-sourcing claims (are hospitals actually staffing ERs themselves, or shifting to other staffing models?). The tone is exploratory but not adversarial enough to surface nuance.
But let's talk about the other side of the model, which is the doctors themselves. Because the PE roll-up also affects physician compensation and work conditions.
So we could be seeing the end of an era. The question is, what replaces it?
Computed from the transcript - who did the talking, and the words that came up most.
Emergency rooms across the US are increasingly staffed not by hospital employees but by physician staffing firms owned by private equity. In this episode, Lucas and Luna drill into the biggest player in this space - Envision Healthcare, which before its 2018 buyout by KKR was the largest ER staffing company in the country. They trace how PE consolidation in emergency medicine has played out, what it means for physician compensation and patient billing - including the practice of 'surprise billing' that Congress banned in 2020 - and why the model faces headwinds from clinician burnout and regulatory pushback. Along the way they touch on TeamHealth, Apollo Global Management, and the No Surprises Act. This is private equity at the intersection of healthcare delivery, labor markets, and federal regulation. #PrivateEquity #ERStaffing #EnvisionHealthcare #KKR #TeamHealth #ApolloGlobalManagement #NoSurprisesAct #SurpriseBilling #PhysicianStaffing #HealthcarePE #EmergencyMedicine #Hospitalist #Anesthesiology #Burnout #RollUp #Finance #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
Transcribed and scored by The B2B Podcast Index.
Lucas: By now, listeners of this show know the playbook. Find a fragmented service industry - vet clinics, dental labs, HVAC companies - buy up the best operators, roll them into a single platform, and sell the combined entity at a multiple arbitrage. That model works beautifully when your raw material is a small business owner who wants to retire. Luna: But today's angle is different.
You're talking about the people who staff emergency rooms. Lucas: Exactly. Because the raw material in this case isn't a company - it's a physician. Specifically, the emergency medicine physician, the hospitalist, the anesthesiologist.
These are doctors who don't work for the hospital. They work for a private physician staffing firm - and the largest of those firms are now owned by private equity. Luna: So the roll-up here is happening in the labor supply to hospitals. And the biggest name in that space, at least in ER staffing, has been Envision Healthcare.
Lucas: Right. Envision was formed through decades of acquisitions. By 2018 it employed something like 25,000 clinicians - physicians, nurse anesthetists, physician assistants - and it was the largest provider of emergency room staffing in the country. That year, KKR took it private in a deal valued at nearly ten billion dollars, including debt.
Luna: Which at the time looked like a bet on the fact that hospitals would keep outsourcing this function. And that the company could use its scale to negotiate better rates with insurers. Lucas: And that's the key economic logic. When a hospital contracts with Envision, Envision bills for the physician's services separately.
And because the physician is out-of-network for many patients, the bill could be much higher than if the doctor were a hospital employee. That created the famous 'surprise bill' - the one you get when you go to an in-network hospital but are treated by an out-of-network doctor you didn't choose. Luna: Which is exactly the practice that Congress targeted with the No Surprises Act, effective 2022. Lucas: That law basically took away the leverage that these staffing firms had.
It says if you go to an in-network facility, you can't be balance-billed for the out-of-network physician. Disputes go to an independent arbitration process. So the whole model - buy up physician groups, stay out-of-network, and bill at the highest rates - gets a lot harder. Luna: And KKR's investment in Envision has been a disaster.
The company filed for Chapter 11 bankruptcy in 2023. KKR lost most of its equity. Lucas: That's right. Envision emerged from bankruptcy in 2024, but the equity was wiped out.
And it's not just Envision. TeamHealth, which is the other big player - owned by private equity firm Apollo Global Management and others - has also struggled. They settled a major Department of Justice investigation in 2022 for over 300 million dollars, tied to allegations of upcoding, basically billing for more severe conditions than were treated. Luna: So the regulatory and legal headwinds are real.
But let's talk about the other side of the model, which is the doctors themselves. Because the PE roll-up also affects physician compensation and work conditions. Lucas: Yes, and this is where the analogy to the HVAC roll-up breaks down. When you buy a local HVAC company, the technicians probably keep their jobs.
But when a private equity firm buys a physician staffing group, it often imposes productivity targets. You need to see more patients per shift, you need to hit certain billing thresholds. That drives burnout in a profession already experiencing high rates of it. Luna: I remember reading that Envision was sued by a group of emergency physicians who claimed the company pressured them to increase admission rates, even when it wasn't medically necessary.
That's a different kind of roll-up problem. Lucas: Exactly. And you see the tension. The PE model depends on squeezing operational efficiencies - but in healthcare, that can conflict with clinical judgment.
The doctors are the product, but they're also the workforce, and they have professional standards and licensing boards. You can't treat them like a hardware store employee. Luna: So what's the state of play right now, mid-2026? Is PE still buying up ER staffing firms, or has the model cooled off?
Lucas: It has definitely cooled. Transaction volume in physician staffing M&A dropped significantly after the No Surprises Act. But PE is still active in adjacent spaces - hospitalist management, anesthesiology groups. There's a firm called NorthStar Anesthesia, backed by PE, that's been acquiring anesthesia practices.
The difference is that now the deals are smaller, and buyers are more cautious about regulatory exposure. Luna: And you mentioned the arbitration process under the No Surprises Act. How has that played out? Lucas: Early data shows that insurers often win the arbitration because they offer payment at the median in-network rate.
So staffing firms are getting paid less than they used to. That directly hurts the revenue models that PE firms used to underwrite their deals. Luna: Which is a good reminder that private equity isn't invincible. When the regulatory environment shifts, so does the ability to generate returns.
Lucas: And that's exactly why I think this is a fascinating case study. It's not just 'PE buys doctors, makes money.' It's 'PE buys doctors, law changes, returns evaporate, doctors are left in a worse position.' Luna: There's a broader lesson there about what happens when the roll-up model meets a highly regulated, human capital intensive industry.
Lucas: Yeah, and speaking of human capital - if you've found value in these conversations about how finance actually works beneath the surface, we do want to mention that listener support is what keeps this show independent. If our episodes have helped you understand a deal or an industry differently, you can buy us a coffee - literally, at buy me a coffee dot com slash fexingo. No pressure, just a way to keep the podcast ad-free. Luna: And it really does make a difference.
Every contribution helps us spend the time digging into a topic like this one. Lucas: Alright, back to the story. So we have a roll-up that went sour. But I want to zoom out - what does this mean for the future of the American hospital?
Because hospitals themselves are also consolidating. Luna: Right, hospital systems are merging into regional giants. If they bring more services in-house - including physician staffing - then the PE staffing model loses its customer base. Lucas: Exactly.
HCA Healthcare, the largest for-profit hospital chain, recently announced it would move more of its ER staffing to employed physicians. That's a direct threat to the independent staffing model. And if the biggest hospital systems follow suit, the entire PE thesis for this sector unravels. Luna: So we could be seeing the end of an era.
The question is, what replaces it? Lucas: I think you'll see more direct employment by hospitals, maybe more unionization of physicians - there's been a push for unionizing resident physicians and even attending physicians. And you'll see private equity move into less-regulated niches, like outpatient clinic management or telemedicine staffing. Luna: So the playbook evolves.
It never really disappears. Lucas: It adapts. And that's what makes this show interesting - watching the cycle repeat with a new twist each time.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.